fbpx

Clinical Studies for Weight Loss, Diabetes, Glucose Control, and Cardiovascular Issues

Welcome! Learn more about our studies here, and sign up using the form below.

We are coordinating several clinical trials for people with a wide range of health conditions who are interested in losing weight, gaining better control of their glucose, or who experience cardiovascular issues.

Please review the options in our menu below, and indicate which study would be of most interest to you by filling out the form beneath the menu or by calling us at (615) 329-2222.

Compensation may be included for participants in each study.

Our team will need to speak with you to determine your interest and if you will qualify for participation.

If you have Type 2 Diabetes, please review the following options:

If you want to help the development of future type 2 diabetes treatment, then the REIMAGINE 3 clinical research study may be for you.

What does this study require?

  1. Study commitment of up to 50 weeks with up to 11 office visits and 33 phone visits
  2. Injection of investigational study medicine with an easy-to-use injection pen once a week
  3. Multiple blood draws
  4. Daily finger sticks to check blood glucose
  5. Maintain a dosing diary and complete questionnaires using a study app

Who can participate?

  1. Must be 18 and older with a diagnosis of type 2 diabetes for more than 180 days
  2. Taking a once daily insulin injection for at least 90 days
  3. BMI ≥ 25 kg/m2 with a HbA1c 7.0-10.5 %

How to learn more

You may call our office at 615-329-2222 and speak with our team or fill out our form below.  Our team will need to speak with you to determine if you are interested and qualify for participation in this research study.  All study related diagnostic tests and study medication are at no cost.  Compensation may be provided for time and travel. 

Do you have type 2 diabetes? 

Are you taking metformin with or without a SGLT2 medication (Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy)? 

You could consider participating in this open label study evaluating the effectiveness of two injectable research medications in terms of glucose control and weight loss.  There are no placebos in this trial. 

What does this study require?

  1. Study commitment of up to 77 weeks with 15 office visits and at least 6 phone calls.
  2. Injection of investigational study medicine with an easy-to-use injection pen once a week
  3. Multiple blood draws and finger sticks (glucose meter and supplies provided)
  4. Maintain a dosing diary and complete questionnaires using a study app

Who can participate?

  1. Must be 18 and older with a diagnosis of type 2 diabetes for more than 6 months
  2. Taking metformin alone or in combination with a SGLT2 inhibitor (Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy)
  3. BMI > 30 with a HbA1c 7.0- 10.5%

Interested in learning more?

You may call our office at 615-329-2222 and speak with our team or fill out our form below.  Our team will need to speak with you to determine if you are interested and qualify for participation in this research study.  All diagnostic tests and study medication are at no cost.  Compensation may be provided for time and travel. 

If you want to help the development of future Type 2 Diabetes treatment, then the REIMAGINE 2 clinical research study may be for you.

You may be eligible to participate in this clinical study if you fulfil the following:

  • 18 years or older
  • Have had type 2 diabetes for more than 180 days (6 months)
  • Have a BMI ≥ 25 kg/m2

What do you need to do?

  • Inject the study medicine with an easy-to-use injection pen once a week
  • Attend regular study-related health checks and medical tests including having blood samples taken
  • Maintain a dosing diary and complete questionnaires using a study app
  • Keep in contact with the study staff during the study at regularly scheduled visits for a duration of one and a half year.

Interested in Learning More?

You may call our office at 615-329-2222 and speak with our team or complete the form below. Our team will need to speak with you to determine your interest and if you may qualify for participation in the study.  All study related diagnostic tests and the study medication are at no cost.  Compensation for time and travel may be available. 

Details about this study will be announced soon. Please fill out our form below if you would like to receive updates.

Weight loss and glucose control are often struggles for people who have Type 2 Diabetes.

Weight loss and diet can be the first treatment recommendation, or what people try to do before seeking help. Many times this is not successful.

If this sounds like you and you are not on any medicine for diabetes, then this may be an opportunity for you.

We are seeking volunteers to participate in a study to evaluate the safety and effectiveness of a once weekly injectable research medication compared to a placebo on weight loss and glucose.  The study will last approximately 44 weeks with 15 visits to our office.  

What does the study require?

  1. High motivation to achieve weight loss and improve glucose control
  2. Commitment to attend required visits
  3. Weekly self-injections
  4. Multiple blood draws
  5. Keeping an ediary

Who can participate?

  1. 18 years of age or older
  2. NOT taking diabetes or weight loss medications
  3. Stable weight for past 3 months
  4. General good health

How to learn more?

Fill out the form below or call our office at (615) 329-2222.

Our team will need to speak with you to determine if you are interested and quality for participation.

There’s no obligation and no insurance required. All study related diagnostic tests and study medication are at no cost. 

Compensation for participants is included in this study. 

If you DO NOT have Type 2 Diabetes, please review the following option:

Many people struggle with obesity and weight related problems.  Maybe you have tried to lose weight with little or no success.  Our research study could be of interest to you.  The purpose of this research study is to evaluate the effectiveness, safety and tolerability of a once a week research medication that is injected once a week compared to a placebo for weight loss and potential improvement of cardiovascular and weight related risk factors.  The study will require multiple office visits and blood draws. 

What is required?

  1. Highly motivated to achieve weight loss
  2. Dietary and physical activity counseling at most visits
  3. Weekly self-injections
  4. Willing to participate for about 114 weeks or more with at least 14 visits and 7 remote visits and follow study procedures including but not limited to lifestyle advice, maintain a diary and complete questionnaires.
  5. Blood draws at most visits

Who can participate?

Must be 18 and older and diagnosed with:

  1. Cardiovascular Disease (previous heart or vascular problems (examples: heart attack, stroke, revascularization procedure (stents etc.), heart failure etc.
  2. BMI ≥ 27
  3. History of some attempt at dietary weight loss.

How to learn more?

You may call our office at 615-329-2222 and speak with our team or fill out the form below. Our team will need to speak with you to determine if you are interested and qualify for participation. There is no obligation and no insurance is required.  All study related diagnostic tests and study medication are at no cost.  Compensation for time and travel may be provided.

Weight Loss, Diabetes, Glucose Control, and Cardiovascular Issues

Name(Required)
MM slash DD slash YYYY
Do you have Type 2 Diabetes?(Required)
Which Study Are You Interested In?
How would you describe yourself?*
*Please check all that apply.
Are you willing to share information about this study with interested friends and family members?
Word of mouth helps improve enrollment, thus reducing the time and cost to research the vaccine.
This field is for validation purposes and should be left unchanged.